Modul 4B. Menyusun Policy Brief
Modul 4B. Menyusun Policy Brief (29 Juli – 2 Agustus 2013)
|
Modul 4B. Menyusun Policy Brief (29 Juli – 2 Agustus 2013)
|
Silahkan mengikuti reportase beberapa sesi yang diikuti oleh Tim UGM dalam bentuk reportase.
Bagian yang ingin membaca seluruh abstrak dapat klik di bagian bawah Tabel Struktur dan akan link ke website International Health Economics Association.
Selamat mengikuti
STRUKTUR KONGRES
Sabtu 6 Juli |
Minggu 7 Juli |
Senin 8 Juli |
Selasa 9 Juli |
Rabu 10 juli |
Registrasi |
Registrasi |
|||
Sesi Pra-Kongres 1 |
Laporan Sesi: Session Title: |
Laporan Sesi: The Impact of Out-of-Pocket Expenditures on Access to Essential MNCH Services in Bangladesh and Opportunities for Improving Coverage: Evidence from the ADB RETA-6515 Study
|
Session Tittle: |
|
Rehat |
Rehat |
Rehat |
Rehat |
|
Diskusi Pra-kongres 1 |
Laporan sesi: Session Title: |
Session: |
Session Tittle: |
|
Waktu Pindah |
Waktu Pindah |
Waktu Pindah |
||
Laporan sesi: |
Session Title: Session : |
Organized Session |
||
Makan Siang |
Makan Siang |
Makan Siang |
Makan Siang |
|
Session Title: |
Panel Session Title: Seminar Panel: Session: |
Session Tittle: |
||
Rehat |
Rehat |
Rehat |
Rehat |
|
Diskusi Pra-Kongres 2 |
Laporan Sesi: |
Session Tittle: |
Session Tittle: |
|
Rehat |
Waktu Pindah |
Waktu Pindah |
Waktu Pindah |
|
9th World Congress on Health Economics: |
Concurrent Session |
Pleno |
International Meeting: |
NO |
Sesi |
Keyword |
|
Kode |
Judul |
||
151 |
Bayside Auditorium B |
Estimating the Effect of Disruptive Technologies and Policies in the US Healthcare Market |
Economics evaluations and methods; Private sector in universal health coverage era; |
152 |
Bayside Auditorium A |
The Effect of Migration on Health, Health Insurance, and Health Behaviors |
Non communicable diseases, tobacco and nutrition; Equity and equality |
153 |
Bayside Terrace |
Affordable Care Act Policies to Expand Coverage: Evidence Public Sector, Employer-Sponsored, and Individual and Small Group Markets |
Health care policy; Health care reform; Universal health coverage |
154 |
Bayside 103 |
An Evolutionary Tale of Five Preference-Weighted Health State Utility Measures |
Economic evaluation and methods |
155 |
Bayside 104 |
Advances in Discrete Choice Experiments among National Policy Makers: Eliciting Equity-Efficiency Preferences in Health |
Discrete Choice Experiments; Health providers and patient choice |
156 |
Bayside 204A |
Methodological Challenges for Estimating Health Service Delivery Costs in Low-Income Settings |
Service delivery, access and healthcare utilization; Economics evaluations and methods; Costs of care |
157 |
Bayside 204B |
Physician-Patient Interaction in the Pharmaceutical Market |
Pharmaceutical and subtances; Patient behavior and behavioral economics |
158 |
Bayside 102 |
Financial Incentives in Health: Evidence from India's Janani Suraksha Yojana |
Health financing; Quality of care; Service delivery, access and healthcare utilization; Maternal and child health |
159 |
Bayside 105 |
Does Price Discrimination have a Place in Pharmaceutical Pricing in Developing Countries? |
Pharmaceutical and subtances; Economic evaluations and methods |
160 |
Bayside 109 |
Economics of Cannabis Use |
Pharmaceutical and subtances; Economic evaluations and methods |
161 |
Bayside 201 |
Pricing, Promotion and Obesity: Implications for Taxation and Regulatory Policies |
Non communicable diseases, tobacco and nutrition; |
162 |
Bayside 202 |
The Costs and Provision of ART Care Across Three Developing Countries |
Quality of care; Costs of care |
163 |
Bayside 203 |
Analysing Unexplained Variations in Performance to Increase the Efficiency of Health Care: Case Studies from the ECHO Project |
Economic evaluations and methods; Quality of care |
164 |
Bayside 106 |
Measuring Universal Health Coverage: Health Service Utilization and the Financial Burden of Health Payments in Asia |
Universal health coverage; Service delivery, access and health care utilization; Health financing |
165 |
Bayside 101 |
India: Quality, Accountability, and Financing Reform |
Quality of care |
166 |
Bayside Auditorium B |
The Origins of Health Economics: Some Reflections on Early Contributors to Health Economic Thought |
Economics evaluations and methods; Equity and equility |
167 |
Bayside Auditorium A |
Health Equity and Financial Protection in Asia Impacts of Health Insurance Reform in Four Countries |
Equity and equality; Health financing; Maternal and child health; Universal health coverage |
168 |
Bayside Terrace |
Use of Discrete Choice Experiments to Elicit End-of-Life Health Care Attitudes and Preferences |
Discrete Choice Experiments |
169 |
Bayside 103 |
Networks in Health Economics |
Economic evaluations and methods; Private sector in universal health coverage era; Health policy |
170 |
Bayside 104 |
Breaking the Addiction to Adoption in Health Economics: Perspectives from Australia, Scotland, Canada and England |
Quality of care; Health care reform |
171 |
Bayside 204A |
Guidelines for Choosing the Appropriate Technique for Multi-Criteria Decision Analysis in Health Care |
Health policy |
172 |
Bayside 204B |
Physician Incentives: Evidence from East Asia |
Health professions; Patient behavior and behavioral economics |
173 |
Bayside 102 |
The Broader Economic Impact of Vaccination in Low and Middle Income Countries: Fiscal Space Related Issues |
Communicable diseases, HIV/AIDS, and vaccines; Health financing |
174 |
Bayside 105 |
Coverage, Value, and Sustainability of Micro Health Insurance on the Indian Subcontinent |
Universal health coverage; Service delivery, access and health care utilization |
175 |
Bayside 109 |
Incentives for Safe Sex: Evaluating Economic Incentives as a Prevention Strategy for HIV and other Sexually Transmitted Infections (STIs) |
Communicable diseases, HIV/AIDS, and vaccines; Economics evaluations and methods |
176 |
Bayside 201 |
Dental Health Economics |
Service delivery, access and healthcare utilization; Economics evaluations and methods; Health financing |
177 |
Bayside 202 |
Efficiency Measurement Incorporating Quality: Exploring New Methodological Approaches |
Quality of care; Health care reform |
178 |
Bayside 203 |
Analytical Advancements in Measuring Development Assistance for Health |
Health policy; Health financing |
179 |
Bayside 106 |
Risky Behaviors and Human Capital |
Impact of health status; Mental health and elderly health issues; Pharmaceutical and subtances; |
180 |
Bayside 101 |
What Can Myanmar Learn from its Neighbours as it Starts its Journey to Achieve Universal Health Coverage? |
Universalh health coverage; Health financing |
181 |
Bayside Auditorium B |
What is the Impact of Health Status |
Impact of health status |
182 |
Bayside Auditorium A |
What Affects Access to Care |
Service delivery, access, and health care utilization; Patient behavior and behavioral economics; Equity and equality |
183 |
Bayside Terrace |
Economic Evaluation of Screening |
Economic evaluations and methods; Costs of care |
184 |
Bayside 103 |
Health Status & Methodology |
Impact of health status; Mental health and elderly health issues |
185 |
Bayside 104 |
Access to Care |
Service delivery, access and health care utilization; Health providers and patient choice; Universal Health Coverage; Equity and equality |
186 |
Bayside 204A |
Allied and Informal Health Providers |
Health professions; Health providers and patient choices; Quality of care; Maternal and child health |
187 |
Bayside 204B |
Impact of Technology |
Quality of care |
188 |
Bayside 102 |
Economic Evaluation of Programmes II |
Economic evaluations and methods; Costs of care |
189 |
Bayside 105 |
Equity & Inequality Issues |
Equity and equility; Universal health coverage |
190 |
Bayside 109 |
Health Insurance for the Poor |
Universal health coverage; Health financing; Equity and equality |
191 |
Bayside 201 |
Universal Health Care |
Universal health care; Equity and equality |
192 |
Bayside 202 |
Issues in Hospitals |
Hospital and hospital management; Health care reform; Quality of care |
193 |
Bayside 203 |
Issues in Drug Costing |
Pharmaceutical and subtances; Health policy; Economics evaluations and methods |
194 |
Bayside 106 |
Utilization |
Cost of care; Quality of care; Service delivery, access and health care utilization; |
195 |
Bayside 101 |
Economics of Smoking |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
196 |
Bayside Auditorium B |
Hospital Payments |
Hospital and hospital management; Economic evaluations and methods; Quality of care |
197 |
Bayside Auditorium A |
Physician Supply |
Health professions; Health policy |
198 |
Bayside Terrace |
Economic Burden of Illness |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
199 |
Bayside 103 |
Prescribing Behaviour |
Health professions; Pharmeceutical and subtances; Costs of care |
200 |
Bayside 104 |
The Impact of Out-of-Pocket Payments |
Economic evaluations and methods; Equity and equality; Health financing |
201 |
Bayside 204A |
Effect of Health Expenditure |
Health care financing; Service delivery, access and health care utilization |
202 |
Bayside 204B |
Cost of Health Care |
Costs of care |
203 |
Bayside 102 |
Issues in Tele-Health |
Health policy; Health reform; Economic evaluations and methods |
204 |
Bayside 105 |
Economics of Obesity II |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
205 |
Bayside 109 |
Health Care Reform |
Health care refrom |
206 |
Bayside 201 |
Improving Hospital Care |
Hospital and hospital management; Quality of care |
207 |
Bayside 203 |
Immunization Economics |
Economics evaluation and methods; Service delivery, access, and health care utilization; Non-communicable disease, tobacco, and nutrition |
208 |
Bayside 106 |
Policy Intervention |
Cost of care; Health policy |
209 |
Bayside 101 |
Treatment Compliance |
Cost of care |
210 |
Bayside Auditorium B |
Applications of Willingness-To-Pay |
Patient behavior and behavioral economics; Health providers and patient choice |
211 |
Bayside Auditorium A |
Insurance in Developing Markets |
Universal health coverage; Service delivery, access, and health care utilization |
212 |
Bayside Terrace |
Taxation Policy |
Economic evaluations and methods |
213 |
Bayside 103 |
Early Child Health |
Maternal and child health; Economic evaluations and methods |
214 |
Bayside 104 |
Paying Doctors |
Health financing |
215 |
Bayside 204A |
Assessing Health Status |
Economic evaluations and methods |
216 |
Bayside 204B |
Issues in Out-of-Pocket Payments |
Health financing; Health policy |
217 |
Bayside 102 |
Assessing Prevention Programs |
Economic evaluation; Quality of care; Health provider and patient choice |
218 |
Bayside 105 |
Subsidizing Insurance |
Service delivery, access and health care utilization; Health providers and patient choice |
219 |
Bayside 109 |
What Affects Health II |
Health status impact; Equity and equality |
220 |
Bayside 201 |
Economic Evaluation II |
Discrete choice experiments; Economic evaluations and methods |
221 |
Bayside 202 |
Health Care Utilization |
Service delivery, access and health care utilization; Maternal and child health |
222 |
Bayside 203 |
Public Health Policy |
Health policy; Health reform; Costs of care |
223 |
Bayside 106 |
Provider Issues |
Health providers and patient choice; Health professions |
224 |
Bayside 101 |
Methodological Issues |
Economic evaluations and methods; Health policy |
225 |
TBA |
ePoster Session |
Non-communicable diseases, HIV/AIDS, and vacciness; Economic evaluations and methods; Cost of care; Health professions; Discrete choice experiments; Mental health and elderly health issues; Pharmaceutical and subtances; Health policy |
Modul 4A. Merancang Policy Brief (22 – 26 Juli 2013)
|
POLICY BRIEF TEMPLATE No more than 2-4 pages, 1500 words |
Executive Summary
|
Introduction
|
Approaches and Results
|
Conclusion
|
Implications and Recommendations
|
Harap kirim ke This email address is being protected from spambots. You need JavaScript enabled to view it. selambat-lambatnya pada tanggal 26 Juli 2013.
Pengantar Modul 4: Mengkomunikasikan hasil-hasil riset kebijakan
|
International Seminar Social Determinants of Health:
|
10 – 12 Juni 2013
Fakultas Kedokteran Universitas Gadjah Mada Yogyakarta
10 Juni 2013 |
||
Waktu |
Kegiatan |
Narasumber |
07.30 – 08.00 |
Registrasi Ulang Peserta |
|
08.00 – 08.30 |
Penjelasan Program Pembukaan Pengenalan Peserta, dan Juri |
Prof. dr. LaksonoTrisnantoro, M.Sc, Ph.D Dekan Fakultas Kedokteran UGM Prof. dr. LaksonoTrisnantoro, M.Sc, Ph.D |
08.30 – 09.45 |
Workshop Perumusan Masalah |
Prof. dr. LaksonoTrisnantoro, M.Sc, Ph.D |
09.45 – 10.00 |
Coffee Break |
|
10.00 – 10.45 |
Presentasi Proposal |
Prof. dr. LaksonoTrisnantoro, M.Sc, Ph.D Nenggih Wahyuni, SIP, MA Dra. Retna Siwi Padmawati, MA dr. Yodi Mahendradhata, M.Sc, Ph.D Dr. Dra. Dumilah Ayuningtyas, MARS |
10.45 – 11.30 |
Workshop Metodologi Mixed Method |
dr. Yodi Mahendradhata, M.Sc, Ph.D |
11.30 – 12.30 |
ISHOMA |
|
12.30 – 13.15 |
Workshop Metodologi Realist Evaluation |
Dr. Yodi Mahendradhata, M.Sc, Ph.D |
13.15 – 14.00 |
Workshop Methodology Case Study |
Dr. Dra. Dumillah Ayuningtyas, MARS |
14.00 – 14.30 |
Coffee Break |
|
14.30 – 15.15 |
Workshop Penyusunan Policy Brief |
Nenggih Wahyuni, SIP, MA |
15.15 – 16.00 |
Lesson Learnt dan Penutup |
Prof. dr. Laksono Trisnantoro, M.Sc., Ph.D |
11 – 12 Juni 2012 |
Modul 3.B Ketrampilan untuk menyampaikan hasil
|